MGNX – Macrogenics Inc
MGNX — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
6.47
Margin Of Safety %
Put/Call OI Ratio
0.09
EPS Next Q Diff
-0.2
EPS Last/This Y
-0.55
EPS This/Next Y
0.75
Price
3.35
Target Price
4
Analyst Recom
2.5
Performance Q
94.77
Upside
-557.9%
Beta
1.11
Ticker: MGNX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | MGNX | 2.35 | 0.07 | 0.00 | 2117 |
| 2026-03-10 | MGNX | 3.44 | 0.06 | 0.06 | 2150 |
| 2026-03-11 | MGNX | 3.34 | 0.10 | 0.28 | 2983 |
| 2026-03-12 | MGNX | 3.13 | 0.12 | 0.63 | 3074 |
| 2026-03-13 | MGNX | 3.12 | 0.12 | 0.55 | 3074 |
| 2026-03-17 | MGNX | 3.09 | 0.12 | 0.20 | 3062 |
| 2026-03-18 | MGNX | 2.97 | 0.13 | 0.72 | 3070 |
| 2026-03-20 | MGNX | 2.86 | 0.12 | 0.11 | 2984 |
| 2026-03-25 | MGNX | 3.16 | 0.08 | 0.58 | 2975 |
| 2026-03-26 | MGNX | 3.18 | 0.11 | 0.10 | 3169 |
| 2026-03-27 | MGNX | 2.92 | 0.10 | 0.01 | 3436 |
| 2026-03-30 | MGNX | 2.76 | 0.09 | 0.00 | 3679 |
| 2026-03-31 | MGNX | 2.88 | 0.09 | 0.00 | 3734 |
| 2026-04-01 | MGNX | 2.9 | 0.09 | 0.00 | 3734 |
| 2026-04-06 | MGNX | 3.17 | 0.09 | 0.00 | 3743 |
| 2026-04-07 | MGNX | 3.35 | 0.09 | 0.00 | 3740 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | MGNX | 2.36 | 97.6 | - | -0.89 |
| 2026-03-10 | MGNX | 3.43 | 97.6 | - | -0.89 |
| 2026-03-11 | MGNX | 3.34 | 97.6 | - | -0.89 |
| 2026-03-12 | MGNX | 3.14 | 97.6 | - | -0.89 |
| 2026-03-13 | MGNX | 3.00 | 97.6 | - | -0.89 |
| 2026-03-17 | MGNX | 3.09 | 97.6 | - | -0.89 |
| 2026-03-18 | MGNX | 2.98 | 97.6 | - | -0.89 |
| 2026-03-19 | MGNX | 2.90 | 97.6 | - | -0.89 |
| 2026-03-20 | MGNX | 2.86 | 36.2 | - | -1.73 |
| 2026-03-23 | MGNX | 2.93 | 36.2 | - | -1.73 |
| 2026-03-24 | MGNX | 2.72 | 36.2 | - | -1.73 |
| 2026-03-25 | MGNX | 3.16 | 36.2 | - | -1.73 |
| 2026-03-26 | MGNX | 3.18 | 36.2 | - | -1.73 |
| 2026-03-27 | MGNX | 2.92 | 36.2 | - | -1.73 |
| 2026-03-30 | MGNX | 2.76 | 36.2 | - | -1.73 |
| 2026-03-31 | MGNX | 2.88 | 36.2 | - | -1.73 |
| 2026-04-01 | MGNX | 2.90 | 36.2 | - | -1.73 |
| 2026-04-02 | MGNX | 3.09 | 36.2 | - | -1.73 |
| 2026-04-06 | MGNX | 3.17 | 36.2 | - | -1.73 |
| 2026-04-07 | MGNX | 3.35 | 36.2 | - | -1.73 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | MGNX | 0.00 | -9.78 | 6.90 |
| 2026-03-10 | MGNX | 0.00 | -9.78 | 6.90 |
| 2026-03-11 | MGNX | 0.00 | -9.78 | 6.68 |
| 2026-03-12 | MGNX | 0.00 | -9.78 | 6.65 |
| 2026-03-13 | MGNX | 0.00 | -9.78 | 6.65 |
| 2026-03-18 | MGNX | 0.00 | -9.74 | 6.65 |
| 2026-03-19 | MGNX | 0.00 | -9.74 | 6.65 |
| 2026-03-20 | MGNX | 0.00 | -9.74 | 6.65 |
| 2026-03-23 | MGNX | 0.00 | -9.74 | 6.65 |
| 2026-03-24 | MGNX | 0.00 | -9.74 | 6.65 |
| 2026-03-25 | MGNX | 0.00 | -9.74 | 6.47 |
| 2026-03-26 | MGNX | 0.00 | -9.74 | 6.47 |
| 2026-03-27 | MGNX | 0.00 | -9.74 | 6.47 |
| 2026-03-30 | MGNX | 0.00 | -9.74 | 6.47 |
| 2026-03-31 | MGNX | 0.00 | -9.74 | 6.47 |
| 2026-04-01 | MGNX | 0.00 | -9.74 | 6.47 |
| 2026-04-02 | MGNX | 0.00 | -9.74 | 6.47 |
| 2026-04-06 | MGNX | 0.00 | -9.71 | 6.47 |
| 2026-04-07 | MGNX | 0.00 | -9.71 | 6.47 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.22
Avg. EPS Est. Current Quarter
-0.41
Avg. EPS Est. Next Quarter
-0.42
Insider Transactions
Institutional Transactions
-9.71
Beta
1.11
Average Sales Estimate Current Quarter
15
Average Sales Estimate Next Quarter
20
Fair Value
Quality Score
39
Growth Score
36
Sentiment Score
80
Actual DrawDown %
90.8
Max Drawdown 5-Year %
-97
Target Price
4
P/E
Forward P/E
PEG
P/S
1.42
P/B
3.82
P/Free Cash Flow
EPS
-1.18
Average EPS Est. Cur. Y
-1.73
EPS Next Y. (Est.)
-0.97
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-49.91
Relative Volume
1.22
Return on Equity vs Sector %
-161.7
Return on Equity vs Industry %
-145.2
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
◆
MGNX
Healthcare
$3.35
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
66.3
Range 1M
94.6%
Sup Dist
8.4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-39%
EPS NY
3.1%
52W%
97.2%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+19.4% upside
Upside
+19.4%
Quality
39
MacroGenics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 293
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule that targets an undisclosed antigen expressed across several solid tumors, which is in preclinical trials. It is also developing T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
MGNX
Latest News
—
Caricamento notizie per MGNX…
stock quote shares MGNX – Macrogenics Inc Stock Price stock today
news today MGNX – Macrogenics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MGNX – Macrogenics Inc yahoo finance google finance
stock history MGNX – Macrogenics Inc invest stock market
stock prices MGNX premarket after hours
ticker MGNX fair value insiders trading